Clinical trial · Observational
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Rare And Cutaneous Non-Hodgkin Lymphoma Registry
NCT01000753CI-TRIAL-00070150completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This research study is collecting and storing tissue samples from patients with rare or cutaneous non-Hodgkin lymphoma. Collecting and storing samples of tissue from patients with cancer to test in the laboratory may help the study of cancer in the future.
Conditions
Conditions (13)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adult Immunoblastic Lymphoma | Adult Immunoblastic Lymphoma | ONTOLOGY_EXACT | 0.98 |
| Central Nervous System Non-Hodgkin Lymphoma | Central Nervous System Non-Hodgkin Lymphoma | ONTOLOGY_EXACT | 0.98 |
| Childhood Immunoblastic Lymphoma | Childhood Immunoblastic Lymphoma | ONTOLOGY_EXACT | 0.98 |
| Grade 1 Follicular Lymphoma | Grade 1 Follicular Lymphoma | ONTOLOGY_EXACT | 0.98 |
| Grade 2 Follicular Lymphoma | Grade 2 Follicular Lymphoma | ONTOLOGY_EXACT | 0.98 |
| Grade 3 Follicular Lymphoma | Grade 3 Follicular Lymphoma | ONTOLOGY_EXACT | 0.98 |
| Lymphoproliferative Disorder | — | UNRESOLVED | — |
| Mantle Cell Lymphoma | Mantle Cell Lymphoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cytology Specimen Collection Procedure | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Observational (specimen collection)
- description
- See Detailed Description
- interventionNames
- Other: Cytology Specimen Collection Procedure
Primary outcomes (4)
- measure
- Clinical features, treatment, and outcomes
- timeFrame
- Up to 5 years
- measure
- Pathologic and biologic features of these diseases, including molecular diagnostics and flow cytometry
- timeFrame
- Up to 5 years
- measure
- Establishment of a bank of these pathologically reviewed diseases and make specimens of blood and tissue available to qualified researchers
- timeFrame
- Up to 5 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of NHL * Any histology, except for Burkitt or Burkitt-like, diffuse large B-cell, anaplastic large cell, or lymphoblastic lymphoma * Primary CNS, primary cutaneous NHL, or lymphoproliferative diseases of any histology allowed * Pathological specimen from site not treated within the past 6 months * Must have specimens available * At least 6 months since prior chemotherapy irradiation to study lesion * At least 2 weeks since prior steroids
References
Publications (0)
Data not yet available
No reference posted for this study.